KAT Innovation ends 2023 with international recognition

The accelerator program FemTech Lab organised a Demo Day in London to allow 11 companies, selected out of more than 140 from around the world, to pitch their projects to investors from the United Kingdom.

 KAT Innovation was part of this very select group of companies from the United States, Singapore, Israel, Canada, Indonesia, the United Kingdom, India, and Estonia.

 As part of this event bringing together 200 people, including several dozen investors, KAT Innovation was awarded the Golden Cheetah award in recognition of the innovation and audacity of its OSTAAT™ medical device.

 The event's organizer, FemTech Lab, works to support startups developing promising medical technologies for women's health. OSTAAT™ is the medical device developed by KAT Innovation aimed at reducing the risk of fractures caused by osteoporosis, including associated with severe chronic kidney disease, of which nearly 80% of victims are women.

KAT Innovation is currently in a fundraising round to finance the next steps leading to the commercialization of the medical device. Visit our website for more information www.katinnovation.com